Erythropoietin promoted the proliferation of hepatocellular carcinoma through hypoxia induced translocation of its specific receptor

BACKGROUND: Erythropoietin (EPO) is a hypoxia-inducible stimulator of erythropoiesis. Besides its traditional application in anemia therapy, it offers an effective treatment in the cancer patients, especially those who receive chemotherapy. Several reports indicated that it could promote the tumor c...

Descripción completa

Detalles Bibliográficos
Autores principales: Miao, Shuo, Wang, Su-Mei, Cheng, Xue, Li, Yao-Feng, Zhang, Qing-Song, Li, Gang, He, Song-Qing, Chen, Xiao-Ping, Wu, Ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Primary Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5725980/
https://www.ncbi.nlm.nih.gov/pubmed/29238266
http://dx.doi.org/10.1186/s12935-017-0494-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5725980/
https://www.ncbi.nlm.nih.gov/pubmed/29238266
http://dx.doi.org/10.1186/s12935-017-0494-7

Ejemplares similares